RxDoctor Payments Data

Donna Hewitt

Nurse Practitioner · Forest City, NCNPI 1710404421

Payments from drug & device makers

$2,808in general payments, 2019–2025

Across 152 payments — averaging $18.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Forte Bio-pharma LLC$1K
  • USWM, LLC$575
  • AbbVie$312
  • Collegium Pharmaceutical, Inc.$206
  • Protega Pharmaceutials Inc$201
  • Virtus Pharmaceuticals LLC$162
  • plus $91 from 4 others

What the payments were for

  • Food & beverage$2,808100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Forte Bio-pharma LLC49$1,261
USWM, LLC54$575
AbbVie15$312
Collegium Pharmaceutical, Inc.12$206
Protega Pharmaceutials Inc9$201
Virtus Pharmaceuticals LLC8$162
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC2$32
Vertex1$22
Pfizer1$20
Averitas Pharma Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,808 in reported general payments places this provider in the 90th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina

Medicare billing

Part B allowed, 2024
$42,760
Medicare patients
69
Services billed
711

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen761$404,695
ProlateOxycodone Hcl/Acetaminophen18$51,387
LinzessLinaclotide89$47,097
Levorphanol Tartrate12$28,005
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl142$24,864
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen535$18,098
Xtampza ErOxycodone Myristate25$15,528
BelbucaBuprenorphine Hcl23$15,232
Oxycodone Hcl694$14,900
Lidocaine65$4,997
Gabapentin461$4,816
Methocarbamol21$3,246
Ondansetron OdtOndansetron131$2,572
Fentanyl20$2,079
Pregabalin106$1,516

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Forte Bio-pharma LLCProlate$1,261$51,38718 claims
AbbVieLinzess$312$47,09789 claims
Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca$206$30,76048 claims
Virtus Pharmaceuticals LLCLevorphanol Tartrate$162$28,00512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,393 nurse practitioner providers in North Carolina.

Other nurse practitioner in Forest City

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →